Stocktoria
Solstice Advanced Materials Inc. SOLS
Solstice Advanced Materials Inc. (SOLS) earns a Piotroski F-score of 3/9 (weak financial health). It pays a dividend yielding 11.42% (safety: at-risk). FY2025 revenue was $3.9B at a 6.1% net margin.
Beneish M-score: -2.94 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-07-31 | UBS | Buy (main) |
| 2026-07-31 | RBC Capital | Outperform (main) |
| 2026-07-16 | BMO Capital | Outperform (main) |
| 2026-07-15 | Mizuho | Neutral (main) |
| 2026-07-13 | UBS | Buy (up) |
| 2026-07-09 | Truist Securities | Buy (up) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| SOLS | Solstice Advanced Materials Inc. | 3/9 | — | 55.4 | +3.1% |
| FMC | FMC CORP | 2/9 | 1.38 | — | -18.3% |
| HUN | Huntsman CORP | 2/9 | 1.92 | — | -5.8% |
| CC | Chemours Co | 4/9 | — | — | +0.4% |
| IOSP | INNOSPEC INC. | 3/9 | 7.54 | — | -3.7% |
| NGVT | Ingevity Corp | 6/9 | 2.97 | — | -2.7% |
| BCPC | BALCHEM CORP | 8/9 | 6.82 | 35.5 | +8.8% |
About Solstice Advanced Materials Inc.
Solstice Advanced Materials, Inc. operates as a specialty chemicals and advanced materials company in the United States and internationally. It operates in two segments: Refrigerants & Applied Solutions (RAS), and Electronic & Specialty Materials (ESM). The RAS segment manufactures and sells low global warming potential (LGWP) refrigerants, blowing agents, solvents, and aerosol materials; and provides, aerosol propellants, cleaning solvents, pharmaceutical packaging materials, and alternative energy services under the Solstice, Genetron, and Aclar brands. The ESM segment offers electronic materials, fibers and laboratory life science chemicals for semiconductor, defense, pharmaceutical, and construction markets. This segment provides sputtering targets, lightweight high-strength fibers, and high-purity life science solutions under the Spectra, Fluka, and Hydranal brands. Solstice Advanced Materials, Inc. was incorporated in 2025 and is headquartered in Morris Plains, New Jersey.
FAQ
Is SOLS financially healthy?
Solstice Advanced Materials Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).
Does SOLS pay a dividend, and is it safe?
Yes. Solstice Advanced Materials Inc. pays a dividend yielding about 11.42% with a 632.9% payout ratio, rated “at-risk” for safety.
How profitable is SOLS?
In FY2025, Solstice Advanced Materials Inc. had a net margin of 6.1% and a return on equity of 16.8%.
What is SOLS's P/E ratio?
Solstice Advanced Materials Inc.'s trailing price-to-earnings (P/E) ratio is about 55.4×, based on its latest annual earnings.
What is the analyst price target for SOLS?
The average Wall-Street price target for Solstice Advanced Materials Inc. is $80.43, about 29.3% above the recent price, from 7 analysts (consensus: buy).
Is SOLS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Solstice Advanced Materials Inc.: a Piotroski F-score of 3/9, a P/E of about 55.4×, a dividend yield of 11.42%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.